ERBB2 and neoplasm: Indeed, subgroup 10 (which includes most of the basal-like tumours) and subgroup 9 (which includes most of the ERBB2 tumours) both exhibited a bad prognosis (with rates of recurrence of 57% and 53%, respectively) in agreement with their higher histological grade (80–100% SBRIII).